Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Janssen-Cilag Ltd
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/04/2012
PIL Evorel Conti

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 09/03/2012 and displayed until 03/04/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
Updated on 06/01/2012 and displayed until 09/03/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 21/07/2009 and displayed until 06/01/2012
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 03/06/2009 and displayed until 21/07/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 22/01/2009 and displayed until 03/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 04/12/2008 and displayed until 22/01/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change to date of revision
  • Addition of Marketing Authorisation Holder
Updated on 03/06/2008 and displayed until 04/12/2008
Reasons for adding or updating:
  • Change to drug interactions
Updated on 06/03/2006 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to appearance of the medicine
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to side-effects
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to date of revision
Updated on 05/05/2005 and displayed until 06/03/2006
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 21/02/2005 and displayed until 05/05/2005
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 07/04/2004 and displayed until 21/02/2005
Reasons for adding or updating:
  • Change of manufacturer
  • Change to Further Information section
  • Change to date of revision
Updated on 04/10/2001 and displayed until 07/04/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 06/07/2000 and displayed until 04/10/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  estradiol hemihydrate
  norethisterone acetate